7. RUHSAT SAHİBİ

AstraZeneca İlaç San. ve Tic. Ltd. Şti.

Büyükdere Cad. Yapı Kredi Plaza

B Blok Kat 3-4

Levent İstanbul

Tel: 0212 317 23 00

8. RUHSAT NUMARASI

26032009127/1

10. KÜB’ÜN YENİLENME TARİHİ

REFERANSLAR

1 SERM Clinical Overview, 2010- June, Shifts in Metabolic Factors. GEL locator: [CNS.000-301-989.2.0].

2 Clinical Overview, 2010-Feb-03, False Positive Results for Methadone and Tricyclic Antidepressants. GEL locator: [CNS.000-291-454.4.0].

3 SERM Clinical Overview, 2009-Dec-03, Decreased Haemoglobin. GEL locator: [CNS.000-288-813.2.0].

4 SERM Clinical Overview, 2010-June, Palpitations. GEL locator: [CNS.000-306-544.2.0].

5 SERM Clinical Overview, 2010-June, Changes in thyroid levels. GEL locator: [CNS.000-306 463.2.0].

6 SERM Clinical Overview, 2010-June, Dyspnea. GEL locator: [CNS.000-306-543.3.0].

7 SERM Clinical Overview, 2010-June, Somnambulism and other related disorders. GEL locator: [CNS.000-306-993.3.0].

8 SERM Clinical Overview, 2010- April, Decreased Neutrophil Count. GEL locator: [CNS.000-302-257.2.0].

SERM Clinical Overview, 2010-June, Overdose. GEL locator: [CNS.000-306-455.3.0]. Clinical Overview, 2009-Aug-7, Updated Suicidality Values. GEL locator: [CNS.000-294-843.2.0]. SERM Clinical Overview, 2009-Dec-03-CLEARS/Cataracts. GEL locator: [CNS.000-289-074.2.0]. International Clinical Overview, 2008-Mar-08, Quetiapine XR for treatment of depression and mania in bipolar disorder (see Table O 4 and following paragraph). GEL locator: [CNS.000-215-024.3.0].